NDC 10631-489 - Isoptin SR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 10631-489
- Package NDCs from labels
- 10631-489-01
- Manufacturer
- Ranbaxy Laboratories Inc.
- Effective date
- 2008-03-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Isoptin SR - Ranbaxy Laboratories Inc. | Ranbaxy Laboratories Inc. | 2008-03-11 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10631-489-01 | Isoptin SR | 100 in 1 BOTTLE | TABLET, COATED | 100 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10631-489-01 | EA - Each | 10631-489 | 5908730d-b5bb-41e4-99bb-937879be31d4 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | A-S Medication Solutions | ed182ebe-8299-4680-9dea-ef79d30db683 | 2026-08-18 | Warnings, Adverse reactions | 897649 |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | REMEDYREPACK INC. | ce9ab27a-e03b-4e40-a0e0-b586cd75dead | 2026-06-29 | Warnings, Adverse reactions | 897640 |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | REMEDYREPACK INC. | 5dc5f087-c8da-4ed0-b532-ae44508958aa | 2026-06-01 | Warnings, Adverse reactions | 897649 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Nivagen Pharmaceuticals, Inc. | e36e485f-fbed-4e30-9a63-984931f2e54e | 2026-05-13 | Warnings, Adverse reactions | 897649 897640 897659 |
| Verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | Zydus Lifesciences Limited | 051392d3-8ec1-450c-8c38-791d4ef1a2db | 2026-04-09 | 897649 897640 897659 | |
| Verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | e19ab8d8-dae5-489d-9805-7e7407bea06d | 2026-04-06 | Warnings, Adverse reactions | 897649 897640 897659 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Bryant Ranch Prepack | 1de6ad5c-942e-4381-b01f-e5e63bbf72ef | 2026-03-10 | Warnings, Adverse reactions | 897640 |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | A-S Medication Solutions | e07b3574-9259-4f64-a9ae-f4e0e64800b6 | 2026-03-07 | Warnings, Adverse reactions | 897659 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Cadila Pharmaceuticals Limited | 5501208c-aa2b-47aa-89f7-87f4d4a73fd0 | 2026-02-09 | Warnings, Adverse reactions | 897649 897640 897659 |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3c215e6c-d85a-4102-a1c2-f00fa3169a55 | 2026-01-08 | Warnings, Adverse reactions | 897649 |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9d529fe3-7b5c-4dde-9a8c-440a969df359 | 2026-01-05 | Warnings, Adverse reactions | 897640 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Northwind Health Company, LLC | db990ce1-b193-4a81-e053-2a95a90a627b | 2026-01-01 | Warnings, Adverse reactions | 897640 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Northwind Health Company, LLC | e08c07bf-58b4-6fa2-e053-2a95a90aca32 | 2026-01-01 | Warnings, Adverse reactions | 897649 |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | Northwind Health Company, LLC | 62c3aadf-412e-41a5-9e57-2c48d962f90a | 2026-01-01 | Warnings, Adverse reactions | 897649 |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | Northwind Health Company, LLC | f7814f9a-e589-4041-e053-6294a90a29e3 | 2026-01-01 | Warnings, Adverse reactions | 897640 |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | Glenmark Pharmaceuticals Inc., USA | ba1bf1ae-9347-4d17-998b-14bf7b5984ce | 2025-12-02 | Warnings, Adverse reactions | 897649 897640 897659 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | REMEDYREPACK INC. | d7c29dfd-3968-41ac-a081-e670f9bd605c | 2025-11-03 | Warnings, Adverse reactions | 897640 |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | af1249b0-e889-4f02-bdc2-54862de0545e | 2025-10-07 | Warnings, Adverse reactions | 897649 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | b0eeada4-1010-4c11-b408-29f9a1af23c0 | 2025-10-07 | Warnings, Adverse reactions | 897659 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | fe05b8d8-fdee-903b-e053-6394a90a2e05 | 2025-02-04 | Warnings, Adverse reactions | 897649 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.